An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 200122
Company: AREVA PHARMS

Products on ANDA 200122

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TERBUTALINE SULFATE	TERBUTALINE SULFATE	1MG/ML	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 200122

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/08/2013	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 200122

TERBUTALINE SULFATE

INJECTABLE;INJECTION; 1MG/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
TERBUTALINE SULFATE	TERBUTALINE SULFATE	1MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	200122	AREVA PHARMS
TERBUTALINE SULFATE	TERBUTALINE SULFATE	1MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	076770	CHARTWELL INJECTABLE
TERBUTALINE SULFATE	TERBUTALINE SULFATE	1MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	076887	FRESENIUS KABI USA
TERBUTALINE SULFATE	TERBUTALINE SULFATE	1MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	078630	HIKMA FARMACEUTICA

Top